Published in Biotechniques on February 01, 1988
Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation. Mol Cell Biol (1993) 6.79
Receptor editing: an approach by autoreactive B cells to escape tolerance. J Exp Med (1993) 5.49
Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc Natl Acad Sci U S A (1993) 2.79
B lymphocytes may escape tolerance by revising their antigen receptors. J Exp Med (1993) 2.78
Human keratinocytes express a new CD44 core protein (CD44E) as a heparan-sulfate intrinsic membrane proteoglycan with additional exons. J Cell Biol (1991) 2.57
Identification of posttranscriptionally active inhibitory sequences in human immunodeficiency virus type 1 RNA: novel level of gene regulation. J Virol (1991) 2.30
Differential localization and sequence analysis of capping protein beta-subunit isoforms of vertebrates. J Cell Biol (1994) 2.00
Transcriptional initiation is controlled by upstream GC-box interactions in a TATAA-less promoter. Mol Cell Biol (1990) 1.90
H36-alpha 7 is a novel integrin alpha chain that is developmentally regulated during skeletal myogenesis. J Cell Biol (1992) 1.89
Latency versus persistence or intermittent recurrences: evidence for a latent state of murine cytomegalovirus in the lungs. J Virol (1997) 1.82
Chemokine gene expression in the brains of mice with lymphocytic choriomeningitis. J Virol (1997) 1.79
Cytochrome P450 CYP1B1 determines susceptibility to 7, 12-dimethylbenz[a]anthracene-induced lymphomas. Proc Natl Acad Sci U S A (1999) 1.73
Phytochrome-mediated light regulation of nitrate reductase expression in squash cotyledons. Plant Physiol (1988) 1.72
Characterization of cDNAs encoding human leukosialin and localization of the leukosialin gene to chromosome 16. Proc Natl Acad Sci U S A (1989) 1.68
Molecular analysis of the INCENPs (inner centromere proteins): separate domains are required for association with microtubules during interphase and with the central spindle during anaphase. J Cell Biol (1993) 1.63
Molecular cloning and expression of abscisic Acid-responsive genes in embryos of dormant wheat seeds. Plant Physiol (1991) 1.60
Focal transcriptional activity of murine cytomegalovirus during latency in the lungs. J Virol (1999) 1.59
Characterization of a guanine nucleotide dissociation stimulator for a ras-related GTPase. EMBO J (1993) 1.59
The defect in Fas mRNA expression in MRL/lpr mice is associated with insertion of the retrotransposon, ETn. J Exp Med (1993) 1.58
Use of 3' untranslated sequences of human cDNAs for rapid chromosome assignment and conversion to STSs: implications for an expression map of the genome. Nucleic Acids Res (1991) 1.55
Identification of a mouse brain cDNA that encodes a protein related to the Alzheimer disease-associated amyloid beta protein precursor. Proc Natl Acad Sci U S A (1992) 1.52
Mammalian DNA ligase III: molecular cloning, chromosomal localization, and expression in spermatocytes undergoing meiotic recombination. Mol Cell Biol (1995) 1.51
The primary structure of NG2, a novel membrane-spanning proteoglycan. J Cell Biol (1991) 1.49
Coordinate regulation of the human TAP1 and LMP2 genes from a shared bidirectional promoter. J Exp Med (1995) 1.46
Isolation of mouse CD44 cDNA: structural features are distinct from the primate cDNA. Proc Natl Acad Sci U S A (1989) 1.42
Cloning, molecular characterization, and chromosomal assignment of a gene encoding a second D1 dopamine receptor subtype: differential expression pattern in rat brain compared with the D1A receptor. Proc Natl Acad Sci U S A (1991) 1.40
Cell-cell adhesion mediated by binding of membrane-anchored transforming growth factor alpha to epidermal growth factor receptors promotes cell proliferation. Proc Natl Acad Sci U S A (1990) 1.40
Epidermal growth factor receptor stimulation activates the RNA binding protein CUG-BP1 and increases expression of C/EBPbeta-LIP in mammary epithelial cells. Mol Cell Biol (2004) 1.39
Layilin, a novel talin-binding transmembrane protein homologous with C-type lectins, is localized in membrane ruffles. J Cell Biol (1998) 1.37
Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression. J Cell Biol (1993) 1.37
Detection and cloning of new HTLV-related endogenous sequences in man. Nucleic Acids Res (1989) 1.36
Interferon-independent, human immunodeficiency virus type 1 gp120-mediated induction of CXCL10/IP-10 gene expression by astrocytes in vivo and in vitro. J Virol (2001) 1.35
Activation of cerebral cytokine gene expression and its correlation with onset of reactive astrocyte and acute-phase response gene expression in scrapie. J Virol (1994) 1.33
G1/S control of anchorage-independent growth in the fibroblast cell cycle. J Cell Biol (1991) 1.33
Molecular isoforms of murine CD44 and evidence that the membrane proximal domain is not critical for hyaluronate recognition. J Cell Biol (1992) 1.27
The immunoglobulin heavy-chain enhancer functions as the promoter for I mu sterile transcription. Mol Cell Biol (1990) 1.21
A novel tau transcript in cultured human neuroblastoma cells expressing nuclear tau. J Cell Biol (1993) 1.20
Immunologic recognition of a 25-amino acid repeat arrayed in tandem on a major antigen of Blastomyces dermatitidis. J Clin Invest (1993) 1.18
Random, asynchronous, and asymmetric transcriptional activity of enhancer-flanking major immediate-early genes ie1/3 and ie2 during murine cytomegalovirus latency in the lungs. J Virol (2001) 1.16
Differential regulation of interferon regulatory factor (IRF)-7 and IRF-9 gene expression in the central nervous system during viral infection. J Virol (2005) 1.15
Expression of multiple water channel activities in Xenopus oocytes injected with mRNA from rat kidney. J Gen Physiol (1993) 1.14
Novel production of interleukin-1 receptor antagonist peptides in normal human cornea. J Clin Invest (1995) 1.13
Paradoxical expression of adenosine deaminase in T cells cultured from a patient with adenosine deaminase deficiency and combine immunodeficiency. J Clin Invest (1990) 1.12
Irreversible loss of the oestrogen receptor in T47D breast cancer cells following prolonged oestrogen deprivation. Br J Cancer (1996) 1.12
Genomic organization, chromosomal localization, and developmentally regulated expression of the glycosyl-phosphatidylinositol-specific phospholipase C of Trypanosoma brucei. Mol Cell Biol (1990) 1.07
The human Pim-1 gene is selectively transcribed in different hemato-lymphoid cell lines in spite of a G + C-rich housekeeping promoter. Mol Cell Biol (1990) 1.07
Post-transcriptional regulation of syndecan-1 expression by cAMP in peritoneal macrophages. J Cell Biol (1993) 1.06
Bone marrow failure by cytomegalovirus is associated with an in vivo deficiency in the expression of essential stromal hemopoietin genes. J Virol (1997) 1.05
Retroviral integration at the Evi-2 locus in BXH-2 myeloid leukemia cell lines disrupts Nf1 expression without changes in steady-state Ras-GTP levels. J Virol (1995) 1.05
Expression of alpha/beta interferons (IFN-alpha/beta) and their relationship to IFN-alpha/beta-induced genes in lymphocytic choriomeningitis. J Virol (1994) 1.05
Molecular structure and expression of the murine lymphocyte low-affinity receptor for IgE (Fc epsilon RII). Proc Natl Acad Sci U S A (1989) 1.01
New sites of proviral integration associated with murine promonocytic leukemias and evidence for alternate modes of c-myb activation. J Virol (1992) 1.01
C10 is a novel chemokine expressed in experimental inflammatory demyelinating disorders that promotes recruitment of macrophages to the central nervous system. Am J Pathol (1999) 0.99
Regulation of c-fos and c-jun protooncogene expression by the Ca(2+)-ATPase inhibitor thapsigargin. Proc Natl Acad Sci U S A (1991) 0.98
Detection of alphafetoprotein-expressing cells in the blood of patients with hepatoma and hepatitis. Br J Cancer (1997) 0.97
Transcriptional suppression of the human T-cell leukemia virus type I long terminal repeat occurs by an unconventional interaction of a CREB factor with the R region. Mol Cell Biol (1994) 0.97
Cultured human atherosclerotic plaque smooth muscle cells retain transforming potential and display enhanced expression of the myc protooncogene. Am J Pathol (1991) 0.97
Identification of a cell-type-specific and E2F-independent mechanism for repression of cdc2 transcription. Mol Cell Biol (1995) 0.95
Characterization of the major locus of immediate-early genes of rat cytomegalovirus. J Virol (1993) 0.95
Increased gene expression of Alzheimer disease beta-amyloid precursor protein in senescent cultured fibroblasts. Proc Natl Acad Sci U S A (1991) 0.93
Macrophage/microglial-mediated primary demyelination and motor disease induced by the central nervous system production of interleukin-3 in transgenic mice. J Clin Invest (1996) 0.92
Novel splicing, missense, and deletion mutations in seven adenosine deaminase-deficient patients with late/delayed onset of combined immunodeficiency disease. Contribution of genotype to phenotype. J Clin Invest (1993) 0.92
Regulation of matrix metalloproteinases and their inhibitor genes in lipopolysaccharide-induced endotoxemia in mice. Am J Pathol (2000) 0.92
Nerve growth factor abrogates the tumorigenicity of human small cell lung cancer cell lines. Proc Natl Acad Sci U S A (1998) 0.91
A dual role for the cAMP-dependent protein kinase in tyrosine hydroxylase gene expression. Proc Natl Acad Sci U S A (1993) 0.90
Tyrosine phosphorylation of a c-Src-like protein is increased in membranes of CD4- CD8- T lymphocytes from lpr/lpr mice. Mol Cell Biol (1989) 0.90
Nerve growth factor in the anterior pituitary: localization in mammotroph cells and cosecretion with prolactin by a dopamine-regulated mechanism. Proc Natl Acad Sci U S A (1996) 0.88
Retroviral insertions in the murine His-1 locus activate the expression of a novel RNA that lacks an extensive open reading frame. Mol Cell Biol (1994) 0.88
Expression of nuclear retinoid receptors in normal, premalignant and malignant gastric tissues determined by in situ hybridization. Br J Cancer (1999) 0.88
Induction of heat shock protein 27 by hydroxyurea and its relationship to experimental metastasis. Clin Exp Metastasis (1998) 0.83
Addition of constitutive c-myc expression to Abelson murine leukemia virus changes the phenotype of the cells transformed by the virus from pre-B-cell lymphomas to plasmacytomas. Mol Cell Biol (1993) 0.83
Islet inflammation and hyperplasia induced by the pancreatic islet-specific overexpression of interleukin-6 in transgenic mice. Am J Pathol (1994) 0.82
Effect of interleukin-4 on the synthesis of the third component of complement by pulmonary epithelial cells. Am J Pathol (1994) 0.79
Cloning and characterization of a 77-kDa oestrogen receptor isolated from a human breast cancer cell line. Br J Cancer (1997) 0.79
C3 synthesis by A549 alveolar epithelial cells is increased by interferon-gamma and dexamethasone. Immunology (1993) 0.78
c-myc antisense oligonucleotides inhibit the colony-forming capacity of Colo 320 colonic carcinoma cells. J Clin Invest (1992) 0.77
Expression of the putative proto-oncogene His-1 in normal and neoplastic tissues. Am J Pathol (1997) 0.77
Modified multiple drug resistance phenotype of Chinese hamster ovary cells selected with X-rays and vincristine versus X-rays only. Br J Cancer (1994) 0.76
Transcriptional promoter of the human alpha 1(V) collagen gene (COL5A1). Biochem J (1995) 0.76
CpG motifs in bacterial DNA trigger direct B-cell activation. Nature (1995) 12.24
New lymphocyte antigen system (Lna) controlled by the Ir region of the mouse H-2 complex. Proc Natl Acad Sci U S A (1973) 4.45
Evidence for the expression of Ia (H-2-associated) antigens on thymus-derived lymphocytes. J Exp Med (1974) 3.56
A simple subtractive hybridization technique employing photoactivatable biotin and phenol extraction. Nucleic Acids Res (1988) 3.46
Cell surface molecule associated with lymphocyte homing is a ubiquitinated branched-chain glycoprotein. Science (1986) 3.33
LCMV-specific, class II-restricted cytotoxic T cells in beta 2-microglobulin-deficient mice. Science (1992) 2.98
Human keratinocytes express a new CD44 core protein (CD44E) as a heparan-sulfate intrinsic membrane proteoglycan with additional exons. J Cell Biol (1991) 2.57
Expression cloning of a lymphocyte homing receptor cDNA: ubiquitin is the reactive species. Science (1986) 2.33
Characterization of responding cells in oxidative mitogen stimulation. II. Identification of an Ia-bearing adherent accessory cell. J Immunol (1980) 2.19
Effects of anti-Ia sera on mitogenic responses. II. Differential expression of the Ia marker on phytohemagglutinin and concanavalin A-reactive T cells. J Exp Med (1976) 2.12
Antigenic relationships of murine coronaviruses: analysis using monoclonal antibodies to JHM (MHV-4) virus. Virology (1983) 2.11
Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles. J Virol (2000) 2.09
Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines. Hepatology (1996) 2.01
Serological and functional evidence for further subdivision of the I regions of the H-2 gene complex. Cold Spring Harb Symp Quant Biol (1977) 1.91
A family of human phosphodiesterases homologous to the dunce learning and memory gene product of Drosophila melanogaster are potential targets for antidepressant drugs. Mol Cell Biol (1993) 1.90
Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) for measurement of cytokine and growth factor mRNA expression with fluorogenic probes or SYBR Green I. Immunol Cell Biol (2001) 1.85
The CH series of murine B cell lymphomas: neoplastic analogues of Ly-1+ normal B cells. Immunol Rev (1986) 1.81
The murine homologue of the T lymphocyte antigen CD28. Molecular cloning and cell surface expression. J Immunol (1990) 1.74
Humoral, mucosal, and cellular immunity in response to a human immunodeficiency virus type 1 immunogen expressed by a Venezuelan equine encephalitis virus vaccine vector. J Virol (1997) 1.73
Identification of a BALB/c H-2Ld gene by DNA-mediated gene transfer. Science (1982) 1.72
Protocadherins: a large family of cadherin-related molecules in central nervous system. EMBO J (1993) 1.72
Murine Ia and human DR antigens: homology of amino-terminal sequences. Proc Natl Acad Sci U S A (1978) 1.70
Recruitment of CD40 and tumor necrosis factor receptor-associated factors 2 and 3 to membrane microdomains during CD40 signaling. J Biol Chem (2000) 1.70
Differential transport requirements of HLA and H-2 class I glycoproteins. Immunogenetics (1989) 1.67
Human immunodeficiency virus type 1-specific cytotoxic T lymphocyte activity is inversely correlated with HIV type 1 viral load in HIV type 1-infected long-term survivors. AIDS Res Hum Retroviruses (1999) 1.66
Inhibition of immune responses in vitro by specific antiserums to Ia antigens. Science (1975) 1.65
Tla types of H-2 congenic and recombinant mice. Transplantation (1974) 1.62
Structural homology between lymphocyte receptors for high endothelium and class III extracellular matrix receptor. Proc Natl Acad Sci U S A (1989) 1.61
A short course of methylprednisolone immunosuppression inhibits both rejection and spontaneous acceptance of rat liver allografts. Transplantation (2001) 1.61
Effects of anti-Ia sera on mitogenic responses. III. Mapping the genes controlling the expression of Ia determinants on concanavalin A-reactive cells to the I-J subregion of the H-2 gene complex. J Exp Med (1976) 1.60
Isolation and DNA sequence of a cDNA clone encoding a lymphocyte adhesion receptor for high endothelium. Proc Natl Acad Sci U S A (1989) 1.60
Increased expression of HLA-DR antigens on renal tubular cells in renal transplants: relevance to the rejection response. Lancet (1984) 1.57
Multiple paths for activation of naive CD8+ T cells: CD4-independent help. J Immunol (2001) 1.54
A novel leukointegrin, alpha d beta 2, binds preferentially to ICAM-3. Immunity (1995) 1.52
Cord blood mononuclear cell cytokine responses in relation to maternal house dust mite allergen exposure. Clin Exp Allergy (2002) 1.51
Product of a transferred H-2Ld gene acts as restriction element for LCMV-specific killer T cells. Nature (1982) 1.50
Varicella-zoster virus Fc receptor gE glycoprotein: serine/threonine and tyrosine phosphorylation of monomeric and dimeric forms. J Virol (1997) 1.50
Differential signaling and tumor necrosis factor receptor-associated factor (TRAF) degradation mediated by CD40 and the Epstein-Barr virus oncoprotein latent membrane protein 1 (LMP1). J Exp Med (2001) 1.48
Induced differentiation of a transformed clone of Ly-1+ B cells by clonal T cells and antigen. Proc Natl Acad Sci U S A (1986) 1.46
Cloning and characterization of a new intercellular adhesion molecule ICAM-R. Nature (1992) 1.46
Cross-clade human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte responses in HIV-infected Zambians. J Virol (1997) 1.45
Isolation of mouse CD44 cDNA: structural features are distinct from the primate cDNA. Proc Natl Acad Sci U S A (1989) 1.42
Acute autoimmune encephalomyelitis in mice. II. Susceptibility is controlled by the combination of H-2 and histamine sensitization genes. J Exp Med (1982) 1.41
Mouse epidermal Ia molecules have a bone marrow origin. Nature (1979) 1.40
DNA sequence and characterization of human class II major histocompatibility complex beta chains from the DR1 haplotype. Proc Natl Acad Sci U S A (1985) 1.39
Effects of anti-Ia serum on mitogenic responses. I. Inhibition of the proliferative response to B cell mitogen, LPS, by specific anti-Ia sera. J Immunol (1975) 1.36
Monoclonal antibodies reactive with H-2 determinants. Immunogenetics (1983) 1.30
Protocadherin Pcdh2 shows properties similar to, but distinct from, those of classical cadherins. J Cell Sci (1995) 1.30
Human osteoblasts express a repertoire of cadherins, which are critical for BMP-2-induced osteogenic differentiation. J Bone Miner Res (1998) 1.30
Mouse genetic locus Lps influences susceptibility to Neisseria meningitidis infection. Infect Immun (1988) 1.27
Relationship between expression of herpes simplex virus glycoproteins and susceptibility of target cells to human natural killer activity. J Exp Med (1983) 1.27
Membrane-bound CD154, but not CD40-specific antibody, mediates NF-kappaB-independent IL-6 production in B cells. Eur J Immunol (1999) 1.25
The defect in delayed-type hypersensitivity of young adult SJL mice is due to a lack of functional antigen-presenting cells. Eur J Immunol (1985) 1.25
Automobile emissions are statistically gamma distributed. Environ Sci Technol (1994) 1.24
T-lymphocyte response to H-2 mutants. I. Proliferation is dependent on Ly 1+2+ cells. J Exp Med (1978) 1.21
The transport of class I major histocompatibility complex antigens is determined by sequences in the alpha 1 and alpha 2 protein domains. Immunogenetics (1990) 1.21
Lymphocyte HEV adhesion variants differ in the expression of multiple gene sequences. Gene (1990) 1.19
Degradation of duplex DNA by S1 nuclease from Aspergillus. Biochem Biophys Res Commun (1974) 1.19
Intrahepatic hepatitis C RNA levels do not correlate with degree of liver injury in patients with chronic hepatitis C. Hepatology (1996) 1.19
Fas-mediated apoptosis in human prostatic carcinoma cell lines. Cancer Res (1997) 1.19
False detection of negative-strand hepatitis C virus RNA. Lancet (1994) 1.18
Naive CD8+ T cells do not require costimulation for proliferation and differentiation into cytotoxic effector cells. J Immunol (2000) 1.17
Characterization of CD40 signaling determinants regulating nuclear factor-kappa B activation in B lymphocytes. J Immunol (1997) 1.17
Specificity of human natural killer cells in limiting dilution culture for determinants of herpes simplex virus type 1 glycoproteins. J Virol (1986) 1.16
Cutting edge: contrasting roles of TNF receptor-associated factor 2 (TRAF2) and TRAF3 in CD40-activated B lymphocyte differentiation. J Immunol (1999) 1.15
Different CD40-mediated signaling events require distinct CD40 structural features. J Immunol (1996) 1.15
Antigen-specific modulation of an immune response by in vivo administration of soluble MHC class I tetramers. J Immunol (2001) 1.15
A point mutation in HLA-A*0201 results in failure to bind the TAP complex and to present virus-derived peptides to CTL. Immunity (1996) 1.15
Different MHC class I alleles compete for presentation of overlapping viral epitopes. Immunity (1995) 1.13
Transgene expression levels and kinetics determine risk of humoral immune response modeled in factor IX knockout and missense mutant mice. Gene Ther (2006) 1.12
Expression and synthesis of murine immune response-associated (Ia) antigens by brain cells. Proc Natl Acad Sci U S A (1981) 1.11
Transfer of lymphocytic choriomeningitis disease in beta 2-microglobulin-deficient mice by CD4+ T cells. Int Immunol (1993) 1.11
On-road vehicle emissions: regulations, costs, and benefits. Science (1995) 1.11
Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants. J Immunol (1984) 1.11
Amino-terminal alteration of the HLA-A*0201-restricted human immunodeficiency virus pol peptide increases complex stability and in vitro immunogenicity. Proc Natl Acad Sci U S A (1995) 1.11
Molecular pathogenesis of liver disease: an approach to hepatic inflammation, cirrhosis and liver transplant tolerance. Immunol Rev (2000) 1.11
Resistance to fatal central nervous system disease by mouse hepatitis virus, strain JHM. II. Adherent cell-mediated protection. J Immunol (1980) 1.10
Absence of MHC class II molecules reduces CNS demyelination, microglial/macrophage infiltration, and twitching in murine globoid cell leukodystrophy. Cell (1994) 1.10
New lymphocyte antigens controlled by the Ir-IgG region of the H-2 gene complex. Transplantation (1974) 1.09
Oxygen binding constants for human hemoglobin tetramers. Biochemistry (1987) 1.09
Chemical characterization of murine Ia alloantigens determined by the i-E/i-C subregions of the H-2 complex. Proc Natl Acad Sci U S A (1977) 1.09
Expression of Ia antigens on T and B cells and their relationship to immune-response functions. Transplant Rev (1976) 1.09
The EBV transforming protein, latent membrane protein 1, mimics and cooperates with CD40 signaling in B lymphocytes. J Immunol (1999) 1.08
Evidence that portal tract microvascular destruction precedes bile duct loss in human liver allograft rejection. Transplantation (1993) 1.08
CD8+ T cells are a biologically relevant source of macrophage inflammatory protein-1 alpha in vivo. J Immunol (1999) 1.08
Mechanism of IL-12 mediated alterations in tumour blood vessel morphology: analysis using whole-tissue mounts. Br J Cancer (2003) 1.07
T lymphocyte response to H-2 mutants: cytotoxic effectors are Ly-1+2+. Proc Natl Acad Sci U S A (1979) 1.07
Fas-dependent CD4+ cytotoxic T-cell-mediated pathogenesis during virus infection. Proc Natl Acad Sci U S A (1996) 1.07
Construction of microcell hybrid clones containing specific mouse chromosomes: application to autosomes 8 and 17. Mol Cell Biol (1982) 1.06
Cytokine profiles in spontaneously regressing basal cell carcinomas. Br J Dermatol (2000) 1.05
T cell activity after dendritic cell vaccination is dependent on both the type of antigen and the mode of delivery. J Immunol (2000) 1.05
Characterization of the roles of TNF receptor-associated factor 6 in CD40-mediated B lymphocyte effector functions. J Immunol (2000) 1.05
Medium spiny neuron projection from the rat striatum: an intracellular horseradish peroxidase study. Brain Res (1980) 1.04
Role of interferon in human natural killer activity against target cells infected with HSV-1. J Immunol (1983) 1.04
Differences in peptide presentation between B27 subtypes: the importance of the P1 side chain in maintaining high affinity peptide binding to B*2703. Immunity (1994) 1.03
Increased intrahepatic messenger RNA expression of interleukins 2, 6, and 8 in human cirrhosis. Gastroenterology (1994) 1.02
Physiological and anatomical studies of the interactions between Purkinje cells and basket cells in the cat's cerebellar cortex: evidence for a unitary relationship. J Neurosci (1989) 1.01
Immunopathology of renal allograft rejection analyzed with monoclonal antibodies to mononuclear cell markers. Kidney Int (1986) 1.01